FindMyKOL
Clinical trialNCT03859752SuspendedPhase 1Interventional

TR1801-ADC in Patients With Tumors That Express c-Met

SponsorOpen Innovation Partners, Inc.Enrollment15Unspecified Adult Solid Tumor, Protocol Specific
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

First-in-human, Phase 1 study to assess safety, tolerability, and pharmacokinetics of TR1801-ADC in patients with select solid tumors that express c-Met.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Southern California Norris Comprehensive Cancer Center

    Los Angeles, California, United States

  • University of Colorado

    Aurora, Colorado, United States

  • John Hopkins - Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland, United States

  • University of Washington / Seattle Cancer Care

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

TR1801-ADC
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Aug 2019
Primary completion
4 Jul 2023
Completion
31 Dec 2023
Last update posted
22 Sept 2023
Registered enrollment
15
Registry id
NCT03859752

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.